Leaders in Clinical Imaging Design and Execution
MMI is an ISO 9001:2008 certified provider of imaging core lab (ICL) services for clinical trials of investigational new drugs and medical devices. We specialize in class III medical devices and surgical procedures. We also support Phase I-IV studies of stem cells, biologics, and pharmaceuticals, which is a growing segment of our business. Since 2000, we have evaluated more than 100 unique treatments for disorders of the musculoskeletal, cardiovascular, and neurological systems. Our experience spans the spectrum of investigational study types and phases, including:
- Pre-Clinical Imaging
- First-in-Human Studies
- Observational Research
- Feasibility Studies
- Pivotal Trials
- Post-Approval Surveillance
- Post-Market Research
Superior Science. Human Delivery.
We deliver global clinical trial management, robust operating infrastructure, and world-class imaging expertise in support of clinical and pre-clinical imaging studies of new treatments within the following therapeutic areas:
Our subspecialty-trained physicians and imaging scientists are clear communicators that will guide you thoughtfully through each step of your trial. Our experts include key opinion leaders and pioneers at the forefront of clinical research and practice. We produce high-quality data necessary for regulatory approval and clear explanations and interpretations of the data that facilitate a thorough understanding of the study outcomes. Our scientific experts and medical writers are dedicated to helping you interpret and report the results of your studies. Hundreds of scientific publications and presentations have featured imaging outcomes illuminated by our experts.
Want to learn more? Browse our services and therapeutic expertise, or contact us.